Industry Research Reports
Global Hemostatic Agents Market Research Report 2025
Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 107 Pages
Report ld: 3471754
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Hemostatic Agents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
The world"s leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Agents.
The Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemostatic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Nursing Homes
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Hemostatic Agents Market Overview
1.1 Product Definition
1.2 Hemostatic Agents by Type
1.2.1 Global Hemostatic Agents Market Value Comparison by Type (2024 VS 2031)
1.2.2 Gelation Sponge
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Others
1.3 Hemostatic Agents by Application
1.3.1 Global Hemostatic Agents Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Nursing Homes
1.4 Global Hemostatic Agents Market Size Estimates and Forecasts
1.4.1 Global Hemostatic Agents Revenue 2020-2031
1.4.2 Global Hemostatic Agents Sales 2020-2031
1.4.3 Global Hemostatic Agents Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hemostatic Agents Market Competition by Manufacturers
2.1 Global Hemostatic Agents Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hemostatic Agents Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hemostatic Agents Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hemostatic Agents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostatic Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostatic Agents, Product Type & Application
2.7 Global Key Manufacturers of Hemostatic Agents, Date of Enter into This Industry
2.8 Global Hemostatic Agents Market Competitive Situation and Trends
2.8.1 Global Hemostatic Agents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hemostatic Agents Players Market Share by Revenue
2.8.3 Global Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemostatic Agents Market Scenario by Region
3.1 Global Hemostatic Agents Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hemostatic Agents Sales by Region: 2020-2031
3.2.1 Global Hemostatic Agents Sales by Region: 2020-2025
3.2.2 Global Hemostatic Agents Sales by Region: 2026-2031
3.3 Global Hemostatic Agents Revenue by Region: 2020-2031
3.3.1 Global Hemostatic Agents Revenue by Region: 2020-2025
3.3.2 Global Hemostatic Agents Revenue by Region: 2026-2031
3.4 North America Hemostatic Agents Market Facts & Figures by Country
3.4.1 North America Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hemostatic Agents Sales by Country (2020-2031)
3.4.3 North America Hemostatic Agents Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostatic Agents Market Facts & Figures by Country
3.5.1 Europe Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hemostatic Agents Sales by Country (2020-2031)
3.5.3 Europe Hemostatic Agents Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic Agents Market Facts & Figures by Region
3.6.1 Asia Pacific Hemostatic Agents Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hemostatic Agents Sales by Region (2020-2031)
3.6.3 Asia Pacific Hemostatic Agents Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hemostatic Agents Market Facts & Figures by Country
3.7.1 Latin America Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hemostatic Agents Sales by Country (2020-2031)
3.7.3 Latin America Hemostatic Agents Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hemostatic Agents Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hemostatic Agents Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hemostatic Agents Sales by Type (2020-2031)
4.1.1 Global Hemostatic Agents Sales by Type (2020-2025)
4.1.2 Global Hemostatic Agents Sales by Type (2026-2031)
4.1.3 Global Hemostatic Agents Sales Market Share by Type (2020-2031)
4.2 Global Hemostatic Agents Revenue by Type (2020-2031)
4.2.1 Global Hemostatic Agents Revenue by Type (2020-2025)
4.2.2 Global Hemostatic Agents Revenue by Type (2026-2031)
4.2.3 Global Hemostatic Agents Revenue Market Share by Type (2020-2031)
4.3 Global Hemostatic Agents Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hemostatic Agents Sales by Application (2020-2031)
5.1.1 Global Hemostatic Agents Sales by Application (2020-2025)
5.1.2 Global Hemostatic Agents Sales by Application (2026-2031)
5.1.3 Global Hemostatic Agents Sales Market Share by Application (2020-2031)
5.2 Global Hemostatic Agents Revenue by Application (2020-2031)
5.2.1 Global Hemostatic Agents Revenue by Application (2020-2025)
5.2.2 Global Hemostatic Agents Revenue by Application (2026-2031)
5.2.3 Global Hemostatic Agents Revenue Market Share by Application (2020-2031)
5.3 Global Hemostatic Agents Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ethicon
6.1.1 Ethicon Company Information
6.1.2 Ethicon Description and Business Overview
6.1.3 Ethicon Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ethicon Hemostatic Agents Product Portfolio
6.1.5 Ethicon Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Hemostatic Agents Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Baxter International
6.3.1 Baxter International Company Information
6.3.2 Baxter International Description and Business Overview
6.3.3 Baxter International Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Baxter International Hemostatic Agents Product Portfolio
6.3.5 Baxter International Recent Developments/Updates
6.4 C. R. Bard
6.4.1 C. R. Bard Company Information
6.4.2 C. R. Bard Description and Business Overview
6.4.3 C. R. Bard Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.4.4 C. R. Bard Hemostatic Agents Product Portfolio
6.4.5 C. R. Bard Recent Developments/Updates
6.5 The Medicines Company
6.5.1 The Medicines Company Company Information
6.5.2 The Medicines Company Description and Business Overview
6.5.3 The Medicines Company Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.5.4 The Medicines Company Hemostatic Agents Product Portfolio
6.5.5 The Medicines Company Recent Developments/Updates
6.6 Anika Therapeutics
6.6.1 Anika Therapeutics Company Information
6.6.2 Anika Therapeutics Description and Business Overview
6.6.3 Anika Therapeutics Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Anika Therapeutics Hemostatic Agents Product Portfolio
6.6.5 Anika Therapeutics Recent Developments/Updates
6.7 Advanced Medical Solutions
6.7.1 Advanced Medical Solutions Company Information
6.7.2 Advanced Medical Solutions Description and Business Overview
6.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Advanced Medical Solutions Hemostatic Agents Product Portfolio
6.7.5 Advanced Medical Solutions Recent Developments/Updates
6.8 Integra LifeSciences
6.8.1 Integra LifeSciences Company Information
6.8.2 Integra LifeSciences Description and Business Overview
6.8.3 Integra LifeSciences Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Integra LifeSciences Hemostatic Agents Product Portfolio
6.8.5 Integra LifeSciences Recent Developments/Updates
6.9 B Braun Melsungen
6.9.1 B Braun Melsungen Company Information
6.9.2 B Braun Melsungen Description and Business Overview
6.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.9.4 B Braun Melsungen Hemostatic Agents Product Portfolio
6.9.5 B Braun Melsungen Recent Developments/Updates
6.10 Gelita Medical
6.10.1 Gelita Medical Company Information
6.10.2 Gelita Medical Description and Business Overview
6.10.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Gelita Medical Hemostatic Agents Product Portfolio
6.10.5 Gelita Medical Recent Developments/Updates
6.11 Equimedical
6.11.1 Equimedical Company Information
6.11.2 Equimedical Description and Business Overview
6.11.3 Equimedical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Equimedical Hemostatic Agents Product Portfolio
6.11.5 Equimedical Recent Developments/Updates
6.12 Vascular Solutions
6.12.1 Vascular Solutions Company Information
6.12.2 Vascular Solutions Description and Business Overview
6.12.3 Vascular Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Vascular Solutions Hemostatic Agents Product Portfolio
6.12.5 Vascular Solutions Recent Developments/Updates
6.13 Marine Polymer Technologies
6.13.1 Marine Polymer Technologies Company Information
6.13.2 Marine Polymer Technologies Description and Business Overview
6.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Marine Polymer Technologies Hemostatic Agents Product Portfolio
6.13.5 Marine Polymer Technologies Recent Developments/Updates
6.14 Z-Medica
6.14.1 Z-Medica Company Information
6.14.2 Z-Medica Description and Business Overview
6.14.3 Z-Medica Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Z-Medica Hemostatic Agents Product Portfolio
6.14.5 Z-Medica Recent Developments/Updates
6.15 CryoLife
6.15.1 CryoLife Company Information
6.15.2 CryoLife Description and Business Overview
6.15.3 CryoLife Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.15.4 CryoLife Hemostatic Agents Product Portfolio
6.15.5 CryoLife Recent Developments/Updates
6.16 BioCer Entwicklungs
6.16.1 BioCer Entwicklungs Company Information
6.16.2 BioCer Entwicklungs Description and Business Overview
6.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.16.4 BioCer Entwicklungs Hemostatic Agents Product Portfolio
6.16.5 BioCer Entwicklungs Recent Developments/Updates
6.17 Biom’Up SAS
6.17.1 Biom’Up SAS Company Information
6.17.2 Biom’Up SAS Description and Business Overview
6.17.3 Biom’Up SAS Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Biom’Up SAS Hemostatic Agents Product Portfolio
6.17.5 Biom’Up SAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic Agents Industry Chain Analysis
7.2 Hemostatic Agents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic Agents Production Mode & Process Analysis
7.4 Hemostatic Agents Sales and Marketing
7.4.1 Hemostatic Agents Sales Channels
7.4.2 Hemostatic Agents Distributors
7.5 Hemostatic Agents Customer Analysis
8 Hemostatic Agents Market Dynamics
8.1 Hemostatic Agents Industry Trends
8.2 Hemostatic Agents Market Drivers
8.3 Hemostatic Agents Market Challenges
8.4 Hemostatic Agents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hemostatic Agents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hemostatic Agents Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hemostatic Agents Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hemostatic Agents Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Hemostatic Agents Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hemostatic Agents Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hemostatic Agents Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hemostatic Agents Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hemostatic Agents, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hemostatic Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hemostatic Agents, Product Type & Application
Table 12. Global Key Manufacturers of Hemostatic Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Agents as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hemostatic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hemostatic Agents Sales by Region (2020-2025) & (K Units)
Table 18. Global Hemostatic Agents Sales Market Share by Region (2020-2025)
Table 19. Global Hemostatic Agents Sales by Region (2026-2031) & (K Units)
Table 20. Global Hemostatic Agents Sales Market Share by Region (2026-2031)
Table 21. Global Hemostatic Agents Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hemostatic Agents Revenue Market Share by Region (2020-2025)
Table 23. Global Hemostatic Agents Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hemostatic Agents Revenue Market Share by Region (2026-2031)
Table 25. North America Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hemostatic Agents Sales by Country (2020-2025) & (K Units)
Table 27. North America Hemostatic Agents Sales by Country (2026-2031) & (K Units)
Table 28. North America Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hemostatic Agents Sales by Country (2020-2025) & (K Units)
Table 32. Europe Hemostatic Agents Sales by Country (2026-2031) & (K Units)
Table 33. Europe Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hemostatic Agents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hemostatic Agents Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Hemostatic Agents Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Hemostatic Agents Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hemostatic Agents Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hemostatic Agents Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Hemostatic Agents Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hemostatic Agents Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Hemostatic Agents Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hemostatic Agents Sales (K Units) by Type (2020-2025)
Table 51. Global Hemostatic Agents Sales (K Units) by Type (2026-2031)
Table 52. Global Hemostatic Agents Sales Market Share by Type (2020-2025)
Table 53. Global Hemostatic Agents Sales Market Share by Type (2026-2031)
Table 54. Global Hemostatic Agents Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hemostatic Agents Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hemostatic Agents Revenue Market Share by Type (2020-2025)
Table 57. Global Hemostatic Agents Revenue Market Share by Type (2026-2031)
Table 58. Global Hemostatic Agents Price (USD/Unit) by Type (2020-2025)
Table 59. Global Hemostatic Agents Price (USD/Unit) by Type (2026-2031)
Table 60. Global Hemostatic Agents Sales (K Units) by Application (2020-2025)
Table 61. Global Hemostatic Agents Sales (K Units) by Application (2026-2031)
Table 62. Global Hemostatic Agents Sales Market Share by Application (2020-2025)
Table 63. Global Hemostatic Agents Sales Market Share by Application (2026-2031)
Table 64. Global Hemostatic Agents Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hemostatic Agents Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hemostatic Agents Revenue Market Share by Application (2020-2025)
Table 67. Global Hemostatic Agents Revenue Market Share by Application (2026-2031)
Table 68. Global Hemostatic Agents Price (USD/Unit) by Application (2020-2025)
Table 69. Global Hemostatic Agents Price (USD/Unit) by Application (2026-2031)
Table 70. Ethicon Company Information
Table 71. Ethicon Description and Business Overview
Table 72. Ethicon Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Ethicon Hemostatic Agents Product
Table 74. Ethicon Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Hemostatic Agents Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Baxter International Company Information
Table 81. Baxter International Description and Business Overview
Table 82. Baxter International Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Baxter International Hemostatic Agents Product
Table 84. Baxter International Recent Developments/Updates
Table 85. C. R. Bard Company Information
Table 86. C. R. Bard Description and Business Overview
Table 87. C. R. Bard Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. C. R. Bard Hemostatic Agents Product
Table 89. C. R. Bard Recent Developments/Updates
Table 90. The Medicines Company Company Information
Table 91. The Medicines Company Description and Business Overview
Table 92. The Medicines Company Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. The Medicines Company Hemostatic Agents Product
Table 94. The Medicines Company Recent Developments/Updates
Table 95. Anika Therapeutics Company Information
Table 96. Anika Therapeutics Description and Business Overview
Table 97. Anika Therapeutics Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Anika Therapeutics Hemostatic Agents Product
Table 99. Anika Therapeutics Recent Developments/Updates
Table 100. Advanced Medical Solutions Company Information
Table 101. Advanced Medical Solutions Description and Business Overview
Table 102. Advanced Medical Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Advanced Medical Solutions Hemostatic Agents Product
Table 104. Advanced Medical Solutions Recent Developments/Updates
Table 105. Integra LifeSciences Company Information
Table 106. Integra LifeSciences Description and Business Overview
Table 107. Integra LifeSciences Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Integra LifeSciences Hemostatic Agents Product
Table 109. Integra LifeSciences Recent Developments/Updates
Table 110. B Braun Melsungen Company Information
Table 111. B Braun Melsungen Description and Business Overview
Table 112. B Braun Melsungen Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. B Braun Melsungen Hemostatic Agents Product
Table 114. B Braun Melsungen Recent Developments/Updates
Table 115. Gelita Medical Company Information
Table 116. Gelita Medical Description and Business Overview
Table 117. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Gelita Medical Hemostatic Agents Product
Table 119. Gelita Medical Recent Developments/Updates
Table 120. Equimedical Company Information
Table 121. Equimedical Description and Business Overview
Table 122. Equimedical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Equimedical Hemostatic Agents Product
Table 124. Equimedical Recent Developments/Updates
Table 125. Vascular Solutions Company Information
Table 126. Vascular Solutions Description and Business Overview
Table 127. Vascular Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Vascular Solutions Hemostatic Agents Product
Table 129. Vascular Solutions Recent Developments/Updates
Table 130. Marine Polymer Technologies Company Information
Table 131. Marine Polymer Technologies Description and Business Overview
Table 132. Marine Polymer Technologies Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Marine Polymer Technologies Hemostatic Agents Product
Table 134. Marine Polymer Technologies Recent Developments/Updates
Table 135. Z-Medica Company Information
Table 136. Z-Medica Description and Business Overview
Table 137. Z-Medica Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Z-Medica Hemostatic Agents Product
Table 139. Z-Medica Recent Developments/Updates
Table 140. CryoLife Company Information
Table 141. CryoLife Description and Business Overview
Table 142. CryoLife Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. CryoLife Hemostatic Agents Product
Table 144. CryoLife Recent Developments/Updates
Table 145. BioCer Entwicklungs Company Information
Table 146. BioCer Entwicklungs Description and Business Overview
Table 147. BioCer Entwicklungs Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. BioCer Entwicklungs Hemostatic Agents Product
Table 149. BioCer Entwicklungs Recent Developments/Updates
Table 150. Biom’Up SAS Company Information
Table 151. Biom’Up SAS Description and Business Overview
Table 152. Biom’Up SAS Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Biom’Up SAS Hemostatic Agents Product
Table 154. Biom’Up SAS Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Hemostatic Agents Distributors List
Table 158. Hemostatic Agents Customers List
Table 159. Hemostatic Agents Market Trends
Table 160. Hemostatic Agents Market Drivers
Table 161. Hemostatic Agents Market Challenges
Table 162. Hemostatic Agents Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hemostatic Agents
Figure 2. Global Hemostatic Agents Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hemostatic Agents Market Share by Type: 2024 & 2031
Figure 4. Gelation Sponge Product Picture
Figure 5. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 6. Others Product Picture
Figure 7. Global Hemostatic Agents Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Hemostatic Agents Market Share by Application: 2024 & 2031
Figure 9. Hospitals
Figure 10. Surgical Centers
Figure 11. Nursing Homes
Figure 12. Global Hemostatic Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Hemostatic Agents Market Size (2020-2031) & (US$ Million)
Figure 14. Global Hemostatic Agents Sales (2020-2031) & (K Units)
Figure 15. Global Hemostatic Agents Average Price (USD/Unit) & (2020-2031)
Figure 16. Hemostatic Agents Report Years Considered
Figure 17. Hemostatic Agents Sales Share by Manufacturers in 2024
Figure 18. Global Hemostatic Agents Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Hemostatic Agents Players: Market Share by Revenue in Hemostatic Agents in 2024
Figure 20. Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Hemostatic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Hemostatic Agents Sales Market Share by Country (2020-2031)
Figure 23. North America Hemostatic Agents Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Hemostatic Agents Sales Market Share by Country (2020-2031)
Figure 27. Europe Hemostatic Agents Revenue Market Share by Country (2020-2031)
Figure 28. Germany Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Hemostatic Agents Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Hemostatic Agents Revenue Market Share by Region (2020-2031)
Figure 35. China Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Hemostatic Agents Sales Market Share by Country (2020-2031)
Figure 46. Latin America Hemostatic Agents Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Hemostatic Agents Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Hemostatic Agents Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Hemostatic Agents by Type (2020-2031)
Figure 56. Global Revenue Market Share of Hemostatic Agents by Type (2020-2031)
Figure 57. Global Hemostatic Agents Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Hemostatic Agents by Application (2020-2031)
Figure 59. Global Revenue Market Share of Hemostatic Agents by Application (2020-2031)
Figure 60. Global Hemostatic Agents Price (USD/Unit) by Application (2020-2031)
Figure 61. Hemostatic Agents Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Hemostatic Agents market?
The top companies in the global Hemostatic Agents market are Ethicon、Pfizer、Baxter International.
Related Reports
Global Hemostatic Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostatic Agents market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 102
USD 4250.00
(Single User License)
Global Hemostatic Agents Market Research Report 2026
The global Hemostatic Agents market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 133
USD 2900.00
(Single User License)
Hemostatic Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostatic Agents was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 148
USD 3950.00
(Single User License)
Global Hemostatic Agents Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostatic Agents market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 171
USD 4900.00
(Single User License)
Global Hemostatic Agents Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostatic Agents was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 162
USD 5900.00
(Single User License)
Global Hemostatic Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostatic Agents market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 108
USD 4250.00
(Single User License)
Hemostatic Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostatic Agents was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 139
USD 3950.00
(Single User License)
Global Hemostatic Agents Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Published Date: 2024-04-17
Pages: 180
USD 5600.00
(Single User License)
Global Hemostatic Agents Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Published Date: 2024-04-16
Pages: 168
USD 5900.00
(Single User License)
Global Hemostatic Agents Market Insights, Forecast to 2030
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Published Date: 2024-04-07
Pages: 112
USD 4900.00
(Single User License)
Global Hemostatic Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostatic Agents market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 102
USD 4250.00 (Single User License)Global Hemostatic Agents Market Research Report 2026
The global Hemostatic Agents market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 133
USD 2900.00 (Single User License)Hemostatic Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostatic Agents was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 148
USD 3950.00 (Single User License)Global Hemostatic Agents Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostatic Agents market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 171
USD 4900.00 (Single User License)Global Hemostatic Agents Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostatic Agents was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 162
USD 5900.00 (Single User License)Global Hemostatic Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostatic Agents market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 108
USD 4250.00 (Single User License)Hemostatic Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostatic Agents was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 139
USD 3950.00 (Single User License)Global Hemostatic Agents Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Published: 2024-04-17
Pages: 180
USD 5600.00 (Single User License)Global Hemostatic Agents Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Published: 2024-04-16
Pages: 168
USD 5900.00 (Single User License)Global Hemostatic Agents Market Insights, Forecast to 2030
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Published: 2024-04-07
Pages: 112
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now